205 related articles for article (PubMed ID: 36512176)
1. The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma.
Chong CY; Goh MS; Porceddu SV; Rischin D; Lim AM
Am J Clin Dermatol; 2023 Jan; 24(1):25-40. PubMed ID: 36512176
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes.
Shalhout SZ; Kaufman HL; Emerick KS; Miller DM
Clin Cancer Res; 2022 Jun; 28(11):2211-2220. PubMed ID: 35121622
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of advanced cutaneous squamous cell carcinoma.
Dessinioti C; Pitoulias M; Stratigos AJ
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):39-50. PubMed ID: 34592000
[TBL] [Abstract][Full Text] [Related]
4. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.
Ashraf S; Alsharedi M
Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872
[TBL] [Abstract][Full Text] [Related]
5. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
6. UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines.
Chen IP; Bender M; Spassova I; Henning S; Kubat L; Fan K; Degenhardt S; Mhamdi-Ghodbani M; Sriram A; Volkmer B; Boukamp P; Becker JC; Greinert R
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3215-3231. PubMed ID: 32865618
[TBL] [Abstract][Full Text] [Related]
7. [ASSOCIATION OF SKIN PHOTOTYPE AND UV EXPOSURE WITH EXPRESSION OF HER RECEPTORS, Ki67 AND p53 IN PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA].
Drvar DL; Lipozenčić J; Mokos ZB; Ilić I; Knežević F
Acta Med Croatica; 2015; 69(5):431-8. PubMed ID: 29087088
[TBL] [Abstract][Full Text] [Related]
8. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
[TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma.
Lavaud J; Blom A; Longvert C; Fort M; Funck-Brentano E; Saiag P
Eur J Dermatol; 2019 Dec; 29(6):636-640. PubMed ID: 31903954
[TBL] [Abstract][Full Text] [Related]
10. Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinoma.
Claveau J; Archambault J; Ernst DS; Giacomantonio C; Limacher JJ; Murray C; Parent F; Zloty D
Curr Oncol; 2020 Aug; 27(4):e399-e407. PubMed ID: 32905333
[TBL] [Abstract][Full Text] [Related]
11. [Dermatology - Update on systemic treatments for locally advanced and/or metastatic cutaneous squamous cell carcinoma].
Brocco E
Rev Med Suisse; 2023 Feb; 19(812):207-211. PubMed ID: 36723649
[TBL] [Abstract][Full Text] [Related]
12. New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma.
Bonini F; de Sousa LG; Ferrarotto R
Expert Opin Emerg Drugs; 2023 Dec; 28(2):97-106. PubMed ID: 37144289
[TBL] [Abstract][Full Text] [Related]
13. Systemic therapy for advanced cutaneous squamous cell carcinoma.
Fitzgerald K; Tsai KK
Semin Cutan Med Surg; 2019 Mar; 38(1):E67-E74. PubMed ID: 31051028
[TBL] [Abstract][Full Text] [Related]
14. Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab.
Stevenson ML; Wang CQ; Abikhair M; Roudiani N; Felsen D; Krueger JG; Pavlick AC; Carucci JA
JAMA Dermatol; 2017 Apr; 153(4):299-303. PubMed ID: 28259107
[TBL] [Abstract][Full Text] [Related]
15. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma.
Ascierto PA; Schadendorf D
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990
[TBL] [Abstract][Full Text] [Related]
16. Immunologic Characteristics of Nonmelanoma Skin Cancers: Implications for Immunotherapy.
Hall ET; Fernandez-Lopez E; Silk AW; Dummer R; Bhatia S
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-10. PubMed ID: 32207669
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
18. Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma.
Benzaquen M
Dermatol Ther; 2020 May; 33(3):e13325. PubMed ID: 32208547
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma.
Boutros A; Cecchi F; Tanda ET; Croce E; Gili R; Arecco L; Spagnolo F; Queirolo P
Front Oncol; 2021; 11():733917. PubMed ID: 34513710
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
Corchado-Cobos R; García-Sancha N; González-Sarmiento R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
